tiprankstipranks
Gland Pharma Ltd. (IN:GLAND)
:GLAND
India Market
Want to see IN:GLAND full AI Analyst Report?

Gland Pharma Ltd. (GLAND) Income Statement

1 Followers

Gland Pharma Ltd. Income Statement

Last quarter (Q2 2026), Gland Pharma Ltd.'s total revenue was ₹14.87B, an increase of 5.76% from the same quarter last year. In Q2, Gland Pharma Ltd.'s net income was ₹1.84B. See Gland Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 64.31B₹ 56.17B₹ 56.65B₹ 36.25B₹ 44.01B
Gross Profit
₹ 19.32B₹ 31.54B₹ 31.11B₹ 17.65B₹ 21.51B
Operating Expenses
₹ 7.26B₹ 14.17B₹ 12.88B₹ 6.08B₹ 5.67B
Depreciation and Amortization
₹ 4.24B₹ 3.59B₹ 3.25B₹ 1.47B₹ 1.10B
EBITDA
₹ 16.30B₹ 12.31B₹ 12.97B₹ 10.31B₹ 15.10B
Operating Income
₹ 12.06B₹ 17.38B₹ 18.23B₹ 11.57B₹ 15.84B
Other Income/Expenses
₹ 2.59B₹ -6.75B₹ -6.90B₹ -1.02B₹ 345.87M
Pretax Income
₹ 14.65B₹ 10.63B₹ 11.33B₹ 10.55B₹ 16.19B
Net Income
₹ 10.27B₹ 6.99B₹ 7.72B₹ 7.81B₹ 12.12B
Per Share Metrics
Basic EPS
₹ 62.35₹ 42.40₹ 46.90₹ 47.44₹ 73.81
Diluted EPS
₹ 62.28₹ 42.40₹ 46.89₹ 47.43₹ 73.64
Weighted Average Shares Outstanding
164.77M 164.75M 164.74M 164.67M 164.54M
Weighted Average Shares Outstanding (Diluted)
164.95M 164.75M 164.73M 164.68M 164.54M
Currency in INR

Gland Pharma Ltd. Earnings and Revenue History